Alnylam Pharmaceuticals Inc 's ability to collect accounts receivable sequentially worsen to 5.37, indicating more challenging environment then in the fourth quarter 2025, but still, it is a far cry from any concerns. Alnylam Pharmaceuticals Inc 's Accounts Receivable average collection period in the Mar 31 2026 quarter, has increased to 68 days, from 67 days, in the Dec 31 2025 quarter.

If we take a look into Healthcare sector 131 other companies have achieved higher receivables turnover ratio. While total ranking has deteriorated relative to the period ending Mar 31 2026 from 589 to 1041.

What is Receivable Turnover Ratio?
What is Alnylam Pharmaceuticals Inc Selling?

What is Receivable Turnover Ratio?

Select the Comparisons :

None ▼

Select the Ratio:

Accounts Receivables Turnover▼

None ▼

Accounts Receivables Turnover▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

ALNY Receivables Turnover Ratio	(Mar 31 2026) I. Quarter	(Dec 31 2025) IV. Quarter	(Sep 30 2025) III. Quarter	(Jun 30 2025) II. Quarter	(Mar 31 2025) I. Quarter
Y / Y Receivable Change	111.46 %	91.85 %	172.65 %	83.25 %	30.08 %
Y / Y Revenue Change	96.43 %	84.95 %	149.35 %	17.26 %	20.2 %
Receivable Turnover Ratio (TTM)	5.37	5.45	5.45	5.65	6.32
ALNY's Total Ranking	# 1041	# 589	# 1391	# 2144	# 1648
Accounts Receivable average collection period days	68	67	67	65	58
Seq. Receivable Change	13.68 %	-19.4 %	70.12 %	35.66 %	3.14 %
Seq. Revenue Change	6.39 %	-12.17 %	61.44 %	30.21 %	0.17 %

Receivable Turnover Company Ranking
Within:	No.
Major Pharmaceutical Preparations Industry	# 32
Healthcare Sector	# 132
Overall Market	# 1041

Receivable Turnover Ratio Statistics
High	Average	Low
0.88	0.23	0.02
(Mar 31 2026)		(Mar 31 2016)

ALNY Company Profile • Back to ALNY Efficiency Comparisons • Compare ALNY Receivables Turnover Ratio to its Competitors

Financial Statements
Alnylam Pharmaceuticals Inc 's Accounts Receivable	$ 884 Millions	Visit ALNY's Balance sheet
Alnylam Pharmaceuticals Inc 's Sales TTM	$ 4,287 Millions	Visit ALNY's Income Statement
Sources of ALNY's Revenues		Visit ALNY's Sales by Geography

Other Accounts Receivable Turnover Ratios
Major Pharmaceutical Preparations Industry Accounts Receivable Turnover Trends and Statistics
Healthcare Sector Accounts Receivable Turnover Statistics
Accounts Receivables Turnover Trends for overall market
ALNY's Receivable Turnover Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Accounts Receivables Turnover
Lowest Ranking Accounts Receivables Turnover

You may also want to know
ALNY's Growth Rates	ALNY's Roa	ALNY's Inventory Turnover Ratio	ALNY's Dividend Comparisons
ALNY's Profitability Ratios	ALNY's Roi	ALNY's Asset Turnover Ratio	ALNY's Dividend Growth
ALNY's Valuation Ratios	ALNY's Roe	ALNY's Financial Strength Ratios	ALNY's Dividend Payout Ratio

Companies with similar Receivables Turnover Ratio for the quarter ending Mar 31 2026, within Healthcare Sector	Receivable Turnover Ratio	Revenues for 12 Months ending Mar 31 2026	Receivable at quarter ending Mar 31 2026
Corcept Therapeutics Inc	13.20	$ 769.096 Millions	$ 58.264 Millions
Rosecliff Acquisition Corp I	13.19	$ 20.547 Millions	$ 1.557 Millions
Xoma Royalty Corporation	13.05	$ 48.555 Millions	$ 3.720 Millions
Mannkind Corporation	13.00	$ 360.783 Millions	$ 27.757 Millions
Lifestance Health Group Inc	12.74	$ 1,494.791 Millions	$ 117.296 Millions
Chemed Corporation	12.73	$ 2,540.548 Millions	$ 199.626 Millions
Milestone Scientific Inc	12.69	$ 8.337 Millions	$ 0.657 Millions
Lftd Partners Inc	12.55	$ 36.955 Millions	$ 2.945 Millions
Clene Inc	12.47	$ 0.134 Millions	$ 0.011 Millions
Skinhealth Systems Inc	12.27	$ 295.223 Millions	$ 24.052 Millions
Cytokinetics Incorporated	12.16	$ 105.815 Millions	$ 8.702 Millions
Precision Biosciences Inc	11.94	$ 45.073 Millions	$ 3.776 Millions
Teladoc Health Inc	11.94	$ 2,514.453 Millions	$ 210.660 Millions
Option Care Health Inc	11.65	$ 5,666.577 Millions	$ 486.439 Millions
Ensysce Biosciences Inc	11.55	$ 4.708 Millions	$ 0.407 Millions
Crinetics Pharmaceuticals Inc	11.52	$ 18.069 Millions	$ 1.569 Millions
Icu Medical Inc	11.46	$ 2,156.379 Millions	$ 188.157 Millions
Nrc Health	11.42	$ 138.642 Millions	$ 12.138 Millions
Nuvation Bio Inc	11.41	$ 142.121 Millions	$ 12.454 Millions
Integrated Biopharma Inc	11.34	$ 47.241 Millions	$ 4.165 Millions
National Healthcare Corp	11.07	$ 1,525.905 Millions	$ 137.813 Millions
Vireo Growth Inc.	11.01	$ 350.469 Millions	$ 31.834 Millions
Bioaffinity Technologies Inc	10.79	$ 5.660 Millions	$ 0.525 Millions
Vivos Therapeutics Inc	10.73	$ 19.092 Millions	$ 1.779 Millions
Veracyte Inc	10.68	$ 516.183 Millions	$ 48.353 Millions
Immucell Corporation	10.51	$ 29.035 Millions	$ 2.762 Millions
Kestra Medical Technologies Ltd	10.51	$ 93.819 Millions	$ 8.925 Millions
Lifeloc Technologies Inc	10.41	$ 9.044 Millions	$ 0.869 Millions
Monte Rosa Therapeutics Inc	10.39	$ 42.953 Millions	$ 4.136 Millions
Escalon Medical Corp	10.35	$ 11.445 Millions	$ 1.106 Millions

Date modified: 2026-05-02T13:23:12+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.